"Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women
Minor Depressive Disorder, Major Depressive Disorder, Post Partum Depression
About this trial
This is an interventional treatment trial for Minor Depressive Disorder focused on measuring e-health, postpartum depression, guided, internet-based
Eligibility Criteria
Inclusion Criteria: Women will be included if they: have a < 6-month-old baby, have a PHQ-9 (Kroenke et al., 2001; Diez-Quevedo et al., 2001) score ≥ 5 points, have minor or major depression according to the Mini-International Neuropsychiatric Interview (MINI: Sheehan et al., 1999; Ferrando et al., 2000), are at least 18 years old, are Chilean residents, are fluent in written and spoken Spanish, self-report ownership of a smartphone, and self-report regular access to the internet. Minor depression will be defined as the presence of two to four concurrent symptoms of depressive disorder (one of which is depressed mood or anhedonia) present most or all the time for at least two weeks, with symptoms causing dysfunction and negative impact on the individual's life (American Psychiatric Association, 2013). Major depression will be defined as the presence of five or more concurrent symptoms of depressive disorder (one of which is depressed mood or anhedonia) present most or all the time for at least two weeks, with symptoms causing dysfunction and a negative impact on the individual's life (American Psychiatric Association, 2013). Exclusion Criteria: Participants exclusion criteria will be the following: illiteracy, risk of suicide, alcohol or substance abuse, bipolar disorder, and psychotic disorder.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Mamá, te entiendo (Mom, I get you)
Waitlist
Participants assigned to this arm will receive a guided 8-week cognitive-behavioral app-based intervention for reducing postpartum depressive symptoms.
Participants in the WL condition will receive the same assessments as those in the intervention condition. Participants allocated to WL may access their local mental health services during their waiting period. In Chile, patients diagnosed with depression by a general practitioner have guaranteed access to treatment at low or no cost. Treatment varies according to depression severity, with group or individual therapy, alone or combined with pharmacotherapy. After the follow-up assessment, the WL group will be offered access to the intervention.